Standalone Sep 2026 half-year: revenue up 42%, after-tax profit INR 249.31 lakh, cash flow negative
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone results for the half year ended 30 September 2026 show revenue from operations of INR 1,481.40 lakh versus INR 1,044.37 lakh in the year-earlier half year, and profit after tax of INR 249.31 lakh versus INR 78.00 lakh. Exceptional credit was INR 61.71 lakh. Net operating cash flow was negative INR 860.66 lakh. Borrowings were 0.15 times equity. Prior figures were regrouped or rearranged. No consolidated or quarterly data are given.
Revenue and profit improved, but negative operating cash flow and an exceptional credit are concerns. Borrowings are low at about 0.15 times equity.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹14.81 Cr | ₹10.44 Cr | +41.8% |
| Operating profit | ₹1.81 Cr | ₹0.62 Cr | +194.0% |
| Profit after tax | — | — | — |
| EBITDA margin | — | — | — |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.